Content Navigation
( All
None )
Target General Information |
Top |
Target ID |
T92517 |
Target Info
|
Target Name |
Calpain-1 (CAPN1) |
Synonyms |
muCANP; PIG30; Micromolar-calpain; Cell proliferation-inducing gene 30 protein; Calpain-1 large subunit; Calpain-1 catalytic subunit; Calpain mu-type; Calcium-activated neutral proteinase 1; CANPL1; CANP 1 |
Target Type |
Patented-recorded Target |
Gene Name |
CAPN1 |
Biochemical Class |
Peptidase |
UniProt ID |
|
Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2012026662 |
Title |
Composition Including Undecylenic Acid and/or Conjugated Linoleic Acid for The Prevention and Treatment of Degenerative Neurological Disorders. |
Abstract |
The present invention relates to a composition including undecylenic acid and/or conjugated linoleic acid for the prevention or treatment of degenerative neurological disorders including Alzheimer's d. |
Applicant(s) |
Ewha University - Industry Collaboration Foundation |
Representative Drug(s) |
D08VAT |
Drug Info
|
N.A. |
[1] |
References |
Top |
REF 1 |
An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.